So the people at Histogen are very nice.. they replied to my email.. feel free to read it...
--------------
There is a possibility of earlier market introduction of HSC in certain Asian countries in advance of US introduction. Strategies are still be firmed in these markets.
Best,
Eileen
From: ************
Sent: Monday, April 02, 2012 4:39 PM
To: Eileen Naughton Brandt
Subject: Re: Contact mail for Histogen
thanks i promise, last question… what about introduction in the asian market?
On Apr 3, 2012, at 4:15 AM, Eileen Naughton Brandt wrote:
Hi **********,
In response to your message, HSC is currently in a Phase I/II clinical trial. We expect to share an update from this trial within the next couple of months. While we continue to estimate the 2016 timeframe for market introduction of HSC within the US, these are only estimates based upon timelines for clinical trials and should not be taken as a schedule.
Best,
Eileen
NOTICE: This email message is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited.
From: **********
Sent: Monday, February 27, 2012 4:03 AM
To: ebrandt@histogeninc.com
Subject: Re: Contact mail for Histogen
Hi Dr Eileen, just wondering when are you aiming to finish trials at this point? there are a lot of rumours that you guys are behind schedule?
sorry to bother again
--------------
There is a possibility of earlier market introduction of HSC in certain Asian countries in advance of US introduction. Strategies are still be firmed in these markets.
Best,
Eileen
From: ************
Sent: Monday, April 02, 2012 4:39 PM
To: Eileen Naughton Brandt
Subject: Re: Contact mail for Histogen
thanks i promise, last question… what about introduction in the asian market?

On Apr 3, 2012, at 4:15 AM, Eileen Naughton Brandt wrote:
Hi **********,
In response to your message, HSC is currently in a Phase I/II clinical trial. We expect to share an update from this trial within the next couple of months. While we continue to estimate the 2016 timeframe for market introduction of HSC within the US, these are only estimates based upon timelines for clinical trials and should not be taken as a schedule.
Best,
Eileen
NOTICE: This email message is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited.
From: **********
Sent: Monday, February 27, 2012 4:03 AM
To: ebrandt@histogeninc.com
Subject: Re: Contact mail for Histogen
Hi Dr Eileen, just wondering when are you aiming to finish trials at this point? there are a lot of rumours that you guys are behind schedule?
sorry to bother again
Comment